5-aminosalicylates (5-Asas) and renal function in inflammatory bowel disease (IBD): A systematic review

被引：0
|
作者：
Gisbert, Javier P.
Gonzalez-Iama, Yago
Mate, Jose
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A359 / A359
页数：1
相关论文
共 50 条
  • [21] Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome
    Shah, Jayshri A.
    Edwards, Cathryn M.
    Probert, Chris S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (03) : 169 - 173
  • [22] Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis
    Ford, Alexander C.
    Kane, Sunanda V.
    Khan, Khurram J.
    Achkar, Jean-Paul
    Talley, Nicholas J.
    Marshall, John K.
    Moayyedi, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04): : 617 - 629
  • [23] Effects of 5-aminosalicylates or thiopurines on the progression of low-grade dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Zeng, Jian
    Meng, Zhang-Min
    Huang, Xiao-Li
    Gan, Hua-Tian
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (01) : 11 - 18
  • [24] Effects of 5-aminosalicylates or thiopurines on the progression of low-grade dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Jian Zeng
    Zhang-Min Meng
    Xiao-Li Huang
    Hua-Tian Gan
    International Journal of Colorectal Disease, 2021, 36 : 11 - 18
  • [25] Urinary glutathion-transferase dosage: A marker for identification of 5-aminosalicylates induced renal toxicity in patients with inflammatory bowel disease?
    Lefebvre, S
    Rousseau, A
    StLouis, G
    Godet, P
    Fugere, J
    Girardin, C
    GASTROENTEROLOGY, 1997, 112 (04) : A1025 - A1025
  • [26] 5-Aminosalicylates to maintain remission in Crohn’s disease:Interpreting conflicting systematic review evidence
    Morris Gordon
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2017, (02) : 99 - 102
  • [27] Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
    Ford, Alexander C.
    Achkar, Jean-Paul
    Khan, Khurram J.
    Kane, Sunanda V.
    Talley, Nicholas J.
    Marshall, John K.
    Moayyedi, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04): : 601 - 616
  • [28] Differences in expression of PPARγ in small intestine vs. colon impact the effect of 5-aminosalicylates in inflammatory bowel disease
    Bakke, I.
    Bruland, T.
    Eriksen, K. S.
    Skovdahl, H. K.
    Gopalakrishnan, S.
    Thorsvik, S.
    Granlund, A. V. B.
    Sandvik, A. K.
    Ostvik, A. E.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S182 - S182
  • [29] Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
    Park, Jihye
    Cheon, Jae Hee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (05): : 895 - 905
  • [30] 5-ASAs in Crohn's Disease: Time to Stop the Salicylate?
    Honap, Sailish
    Sharma, Esha
    Samaan, Mark A.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) : 2699 - 2700
12345